CHK Methylation Is Elevated in Colon Cancer Cells and Contributes to the Oncogenic Properties

Src is an important oncogene that plays key roles in multiple signal transduction pathways. Csk-homologous kinase (CHK) is a kinase whose molecular roles are largely uncharacterized. We previously reported expression of CHK in normal human colon cells, and decreased levels of CHK protein in colon ca...

Full description

Bibliographic Details
Main Authors: Shudong Zhu, Yan Zhu, Qiuwen Wang, Yi Zhang, Xialing Guo
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2021.708038/full
_version_ 1819289636997955584
author Shudong Zhu
Shudong Zhu
Shudong Zhu
Yan Zhu
Yan Zhu
Qiuwen Wang
Yi Zhang
Xialing Guo
author_facet Shudong Zhu
Shudong Zhu
Shudong Zhu
Yan Zhu
Yan Zhu
Qiuwen Wang
Yi Zhang
Xialing Guo
author_sort Shudong Zhu
collection DOAJ
description Src is an important oncogene that plays key roles in multiple signal transduction pathways. Csk-homologous kinase (CHK) is a kinase whose molecular roles are largely uncharacterized. We previously reported expression of CHK in normal human colon cells, and decreased levels of CHK protein in colon cancer cells leads to the activation of Src (Zhu et al., 2008). However, how CHK protein expression is downregulated in colon cancer cells has been unknown. We report herein that CHK mRNA was decreased in colon cancer cells as compared to normal colon cells, and similarly in human tissues of normal colon and colon cancer. Increased levels of DNA methylation at promotor CpG islands of CHK gene were observed in colon cancer cells and human colon cancer tissues as compared to their normal healthy counterparts. Increased levels of DNA methyltransferases (DNMTs) were also observed in colon cancer cells and tissues. DNA methylation and decreased expression of CHK mRNA were inhibited by DNMT inhibitor 5-Aza-CdR. Cell proliferation, colony growth, wound healing, and Matrigel invasion were all decreased in the presence of 5-Aza-CdR. These results suggest that increased levels of DNA methylation, possibly induced by enhanced levels of DNMT, leads to decreased expression of CHK mRNA and CHK protein, promoting increased oncogenic properties in colon cancer cells.
first_indexed 2024-12-24T03:10:00Z
format Article
id doaj.art-8d34e56239664a52b3c008402f073c9b
institution Directory Open Access Journal
issn 2296-634X
language English
last_indexed 2024-12-24T03:10:00Z
publishDate 2021-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cell and Developmental Biology
spelling doaj.art-8d34e56239664a52b3c008402f073c9b2022-12-21T17:17:51ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2021-06-01910.3389/fcell.2021.708038708038CHK Methylation Is Elevated in Colon Cancer Cells and Contributes to the Oncogenic PropertiesShudong Zhu0Shudong Zhu1Shudong Zhu2Yan Zhu3Yan Zhu4Qiuwen Wang5Yi Zhang6Xialing Guo7School of Medicine, Nantong University, Nantong, ChinaDepartment of Biochemistry and Molecular Biology, School of Life Science, Central South University, Changsha, ChinaXuzhou Health Research Institute, Xuzhou, ChinaSchool of Medicine, Nantong University, Nantong, ChinaXuzhou Health Research Institute, Xuzhou, ChinaDepartment of Biochemistry and Molecular Biology, School of Life Science, Central South University, Changsha, ChinaDepartment of Gastrointestinal Surgery, The Third Xiangya Hospital, School of Life Science, Central South University, Changsha, ChinaArgus Pharmaceuticals, Changsha, ChinaSrc is an important oncogene that plays key roles in multiple signal transduction pathways. Csk-homologous kinase (CHK) is a kinase whose molecular roles are largely uncharacterized. We previously reported expression of CHK in normal human colon cells, and decreased levels of CHK protein in colon cancer cells leads to the activation of Src (Zhu et al., 2008). However, how CHK protein expression is downregulated in colon cancer cells has been unknown. We report herein that CHK mRNA was decreased in colon cancer cells as compared to normal colon cells, and similarly in human tissues of normal colon and colon cancer. Increased levels of DNA methylation at promotor CpG islands of CHK gene were observed in colon cancer cells and human colon cancer tissues as compared to their normal healthy counterparts. Increased levels of DNA methyltransferases (DNMTs) were also observed in colon cancer cells and tissues. DNA methylation and decreased expression of CHK mRNA were inhibited by DNMT inhibitor 5-Aza-CdR. Cell proliferation, colony growth, wound healing, and Matrigel invasion were all decreased in the presence of 5-Aza-CdR. These results suggest that increased levels of DNA methylation, possibly induced by enhanced levels of DNMT, leads to decreased expression of CHK mRNA and CHK protein, promoting increased oncogenic properties in colon cancer cells.https://www.frontiersin.org/articles/10.3389/fcell.2021.708038/fullCHKcolon cancerDNA methylationFHCdrug resistance
spellingShingle Shudong Zhu
Shudong Zhu
Shudong Zhu
Yan Zhu
Yan Zhu
Qiuwen Wang
Yi Zhang
Xialing Guo
CHK Methylation Is Elevated in Colon Cancer Cells and Contributes to the Oncogenic Properties
Frontiers in Cell and Developmental Biology
CHK
colon cancer
DNA methylation
FHC
drug resistance
title CHK Methylation Is Elevated in Colon Cancer Cells and Contributes to the Oncogenic Properties
title_full CHK Methylation Is Elevated in Colon Cancer Cells and Contributes to the Oncogenic Properties
title_fullStr CHK Methylation Is Elevated in Colon Cancer Cells and Contributes to the Oncogenic Properties
title_full_unstemmed CHK Methylation Is Elevated in Colon Cancer Cells and Contributes to the Oncogenic Properties
title_short CHK Methylation Is Elevated in Colon Cancer Cells and Contributes to the Oncogenic Properties
title_sort chk methylation is elevated in colon cancer cells and contributes to the oncogenic properties
topic CHK
colon cancer
DNA methylation
FHC
drug resistance
url https://www.frontiersin.org/articles/10.3389/fcell.2021.708038/full
work_keys_str_mv AT shudongzhu chkmethylationiselevatedincoloncancercellsandcontributestotheoncogenicproperties
AT shudongzhu chkmethylationiselevatedincoloncancercellsandcontributestotheoncogenicproperties
AT shudongzhu chkmethylationiselevatedincoloncancercellsandcontributestotheoncogenicproperties
AT yanzhu chkmethylationiselevatedincoloncancercellsandcontributestotheoncogenicproperties
AT yanzhu chkmethylationiselevatedincoloncancercellsandcontributestotheoncogenicproperties
AT qiuwenwang chkmethylationiselevatedincoloncancercellsandcontributestotheoncogenicproperties
AT yizhang chkmethylationiselevatedincoloncancercellsandcontributestotheoncogenicproperties
AT xialingguo chkmethylationiselevatedincoloncancercellsandcontributestotheoncogenicproperties